Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Histopathologic Features of an Attenuated Onychomatricoma: A Novel Variant.

Created on 06 Oct 2026

Authors

Archie Spindler, Derek Maas, Erika Koh, Shari R Lipner, Natalia V Chalupczak, Kristen I Lo Sicco, George Jour, Ata S Moshiri, Alexandra Flamm, Michael Occidental, Garrett Desman, Adam I Rubin

Published in

Journal of cutaneous pathology. Oct 05, 2026. Epub Oct 05, 2026.

Abstract

Onychomatricoma (OM) is a rare benign fibroepithelial nail unit tumor that remains frequently underrecognized, with evolving histopathologic criteria. Existing descriptions have largely focused on well-developed lesions, leaving the histopathologic features of smaller, localized lesions poorly characterized. We report an attenuated OM in a 45-year-old woman highlighting subtle but characteristic histopathologic features of OM, including a focal CD34-positive spindle cell population in the superficial submatrical dermis, matrical epithelial papillation, and focal serum-filled cavity formation within the nail plate. Compared with classic OM, these findings were more localized and less architecturally developed, while still retaining key diagnostic features. Improved recognition of these subtle features in attenuated lesions will facilitate earlier diagnosis, reduce misclassification, and refine clinicopathologic criteria for this important nail unit tumor.

PMID:
42834485
Bibliographic data and abstract were imported from PubMed on 06 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement